TILT Enters Into Definitive Agreement to Sell Substantially All Assets of its Inactive Wholly-Owned Subsidiary, Sante Veritas Therapeutics, for C$900,000 PHOENIX, Oct. 28, 2021 (GLOBE NEWSWIRE) — TILT Holdings...